Innovative solutions for delivering active ingredients are emerging from numerous groundbreaking research and implementations, including lipid nanocarriers (LNPs). For drug delivery or gene therapy to be brought to market by many pharmaceutical companies, appropriate research and development of solutions that support the development of modern medicine and biotechnology are essential. SyVento BioTech is a company operating in this field. What can be told about its business?

• SyVento BioTech and its solutions
• Strategic partnership is the key to developing further business activities

SyVento BioTech and its solutions

SyVento BioTech operates in several core areas. It works to develop the best way to deliver therapeutic molecules. These include small molecules, RNA, DNA, and proteins.

The company provides professional consulting and advisory services aimed at ensuring high-quality, reliable products and developing a product that is cost-effective and financially advantageous for the client.

Leveraging our specialised knowledge and years of experience in developing lipid-based drug delivery systems, we protect delicate molecules that canquickly degrade without protection.

Using professional and specialised equipment also enables production on any scale – from small scale to large-scale production.

All comprehensive research is aimed at product development, research, testing, and production, as well as supporting its market launch and further refinement.

Strategic partnership is the key to developing further business activities

Close collaboration with numerous partners is crucial to ensuring an efficient, smooth, and effective product development process. Each collaboration is based on a personalised approach to the needs of each client in the pharmaceutical industry and the development of academic projects.

An interdisciplinary team of experts also helps strengthen existing market partners, supports innovation, and cooperation with reliable, respected partners significantly affects the credibility of SyVento BioTech.

The integration of research, technology, production, professional support, experience, knowledge, and know-how makes SyVento BioTech one of the leaders in the European biotechnology market. Its activities contribute to the development of modern RNA therapies and next-generation drugs in compliance with the highest quality standards, based on the company’s strategy. This gives the company real growth potential and key importance for the further development of medicine.